Janice Kelly1. 1. Cystic Fibrosis Canada, 2323 Yonge Street, Suite 800, Toronto, ON M4P 2C9, Canada. Electronic address: jkelly@cysticfibrosis.ca.
Abstract
BACKGROUND: Cystic fibrosis (CF) is a rare fatal genetic disease, affecting 70,000 to 100,000 people worldwide [1]. Numerous countries have specific charitable organizations dedicated to CF, with many funding research to find a cure or effective control for the disease. Cystic Fibrosis Canada, the largest charity in Canada dedicated to funding research and care in CF, conducted an environmental scan of these organizations to learn and better understand their research goals and funding process. METHODS: A set of questions was sent to 25 CF charitable organizations around the world by email. Responses were consolidated to identify common practices and innovative approaches. RESULTS: Among respondents, there were variations in the amount of funds invested in research annually and the number of studies supported. Common themes identified included practicing an open call for research applications, evaluating applications using a peer review process, and placing an increased emphasis on patient engagement. Innovative approaches included funding one larger project; funding a series of sub-projects on a common theme; partially funding a research project; and, indefinitely funding part of a researcher's salary. CONCLUSIONS: Among CF charitable organizations, there are numerous approaches to research funding. Both similarities and differences were noted between these organizations, all of which share the common goal of working towards improving quality of life and survival for people with CF.
BACKGROUND:Cystic fibrosis (CF) is a rare fatal genetic disease, affecting 70,000 to 100,000 people worldwide [1]. Numerous countries have specific charitable organizations dedicated to CF, with many funding research to find a cure or effective control for the disease. Cystic Fibrosis Canada, the largest charity in Canada dedicated to funding research and care in CF, conducted an environmental scan of these organizations to learn and better understand their research goals and funding process. METHODS: A set of questions was sent to 25 CF charitable organizations around the world by email. Responses were consolidated to identify common practices and innovative approaches. RESULTS: Among respondents, there were variations in the amount of funds invested in research annually and the number of studies supported. Common themes identified included practicing an open call for research applications, evaluating applications using a peer review process, and placing an increased emphasis on patient engagement. Innovative approaches included funding one larger project; funding a series of sub-projects on a common theme; partially funding a research project; and, indefinitely funding part of a researcher's salary. CONCLUSIONS: Among CF charitable organizations, there are numerous approaches to research funding. Both similarities and differences were noted between these organizations, all of which share the common goal of working towards improving quality of life and survival for people with CF.
Authors: José J Degrossi; Cindy Merino; Adela M Isasmendi; Lorena M Ibarra; Chelsea Collins; Nicolás E Bo; Mariana Papalia; Jennifer S Fernandez; Claudia M Hernandez; Krisztina M Papp-Wallace; Robert A Bonomo; Miryam S Vazquez; Pablo Power; María S Ramirez Journal: Curr Microbiol Date: 2019-02-19 Impact factor: 2.188
Authors: Eric W F W Alton; A Christopher Boyd; Jane C Davies; Deborah R Gill; Uta Griesenbach; Tracy E Harman; Stephen Hyde; Gerry McLachlan Journal: Hum Gene Ther Date: 2020-09 Impact factor: 5.695
Authors: Livia Delpiano; Joseph J Thomas; Annabel R Yates; Sarah J Rice; Michael A Gray; Vinciane Saint-Criq Journal: Front Pharmacol Date: 2018-12-11 Impact factor: 5.810